| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000018092 |
| Receipt No. | R000020942 |
| Official scientific title of the study | Femoral nerve articular branch block:it's efficacy in pain relief for elderly patients after hip arthroplasty |
| Date of disclosure of the study information | 2015/06/25 |
| Last modified on | 2016/04/03 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Femoral nerve articular branch block:it's efficacy in pain relief for elderly patients after hip arthroplasty | |
| Title of the study (Brief title) | Femoral nerve articular branch block:it's efficacy in pain relief for elderly patients after hip arthroplasty | |
| Region |
|
|
| Condition | |||
| Condition | proximal femoral fractures | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Proximal femoral fractures are more common in elderly people. Severe pain may lead to delirium and delay the recovery. Therefore, The purpose of this study was to assess the effectiveness of femoral nerve of articular branch. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | FRS(Face Rating Scale) |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Femoral nerve of articular branch block | |
| Interventions/Control_2 | None | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients whose American Society of Anesthesiologists Physical Status are 1-3, planned to hip arthroplasty and agree to Femoral nerve of articular branch block for postoperative analgesia are enrolled in this study. | |||
| Key exclusion criteria | Exclude criteria are the patients who have local anesthetic allergy or peripheral neuropathy or coagulation abnormality liver dysfunction(child-pugh score>B), renal dysfunction (eGFR<60). | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiro Sugiura |
| Organization | National hospital organization Tokyo Medical Center |
| Division name | Anesthesiology |
| Address | 2-5-1, Higashigaoka Meguro-ku Tokyo 152-8902 |
| TEL | 03-3411-0111 |
| sugiura.takahiro@navy.plala.or.jp | |
| Public contact | |
| Name of contact person | Takahiro Sugiura |
| Organization | National hospital organization Tokyo Medical Center |
| Division name | Anesthesiology |
| Address | 2-5-1, Higashigaoka Meguro-ku Tokyo 152-8902 |
| TEL | 03-3411-0111 |
| Homepage URL | |
| sugiura.takahiro@navy.plala.or.jp | |
| Sponsor | |
| Institute | National hospital organization Tokyo Medical Center |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000020942 |